Loading...

MREO MEREO BIOPHARMA GROUP PLC Investments/Divestments 8-K Filing

MR B

MR

MEREO BIOPHARMA GROUP PLC

(MREO)

2024 8-K

Director Resignation

Financial Results Announced

Delisting Notification

Clinical Study Results

Q3 Financial Results

Product Expansion

Financial Statements

Financial Results

Clinical Update

License Agreement Update

Q2 Financial Results

Underwriting Agreement

Interim Data from Phase 2/3...

Financial Results Announcement

Extension Agreement with Ru...

Financial Results Announcement

External Links:

Mereo Biopharma Group Plc entered into an underwriting agreement for an underwritten offering of American Depositary Shares (ADSs) at a price of $3.99 per ADS, expected to close on June 17, 2024, with net proceeds of approximately $45.9 million.

AI Assistant

MEREO BIOPHARMA GROUP PLC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.